VEGFD and colorectal carcinoma: Similar results were reported in colorectal carcinoma patients who received a bevacizumab plus FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) regimen; further, VEGF-A significantly decreased while VEGF-D significantly increased during the treatment process [25].